ONWARD Health Research Revenue

About ONWARD Health Research

We are in the midst of a biological revolution, yet the current methods for testing and evaluating healthcare innovations—whether new medicines, medical devices, or digital health products—exclude nearly half of the world’s population. This omission puts healthcare innovators at risk of developing products that may be less safe, less effective, and less accessible for over 4 billion people. Today, 80% of the world’s clinical trials are conducted in just three regions: the U.S., EU, and Northeast Asia. This geographic concentration leaves vast populations underrepresented in the data that drives healthcare innovation. We are based in Singapore, and our beachhead market is Indonesia, where we are already collaborating with healthcare systems and the Ministry of Health to expand clinical research in the world's fourth most populous country. To facilitate this, we developed ONWARDAccess, a cutting-edge digital platform for data collection and workflow management. ONWARDAccess will evolve into a global marketplace that connects hospitals in these regions with healthcare innovators worldwide. This platform enables healthcare organizations to conduct world-class clinical research and access new clinical trial opportunities, bridging the gap between innovators and the populations they aim to serve. Our mission is clear: to ensure that the biological revolution produces treatments and technologies developed in a responsible, inclusive manner—creating medicines, devices, and digital health solutions that are not only safe and effective but also more equitable and accessible for everyone. Join us on this journey to revolutionize healthcare by creating a more inclusive global clinical research ecosystem. Together, we can build a future where healthcare innovations truly benefit everyone.

View contact profiles from ONWARD Health Research